Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 27, 2020

Bayer to acquire Asklepios BioPharmaceutical for up to $4bn

German pharmaceutical and life sciences company Bayer has agreed to acquire US-based clinical-stage gene therapy company Asklepios BioPharmaceutical (AskBio) for up to $4bn.

Image: AskBio bioreactor. (Credit: Bayer AG)